Molecular Testing for Endometrial Cancer: A Society of Gynecologic Oncology Podcast
Description
Moderator: Kari Hacker, MD, PhD, Gynecologic Oncologist, New York University Langone Health
Speakers:
Christine Walsh, MD, MS, Gynecologic Oncologist, University of Colorado
Carolyn McCourt, MD, Gynecologic Oncologist, Washington University School of Medicine
Kari Hacker, MD, PhD, is joined by Christine Walsh, MD, MS, and Carolyn McCourt, MD, to review basic molecular classification as well as more complex biomarkers in endometrial cancer. They discuss how testing can be utilized to inform patient prognosis and to guide second line systemic treatment decisions. They also highlight several ongoing trials investigating treatment strategies based on molecular features, the results of which will help clinicians make better therapeutic decisions, resulting in better outcomes for patients with endometrial cancer. This podcast was developed by the Society of Gynecologic Oncology for Gynecologic Oncology.
Additional Resources: Molecular testing for endometrial cancer: An SGO clinical practice statement
Editor’s Choice Paper:
Identifying safe diagnostic algorithms for sentinel lymph node mapping in high-risk endometrial cancer: The SENTIREC-endo study
Editorial:
Sentinel lymph node biopsy in high-risk endometrial cancer: The dénouement
Hosted by:
Gregg Nelson, MD, Social Media Editor...
Published 04/15/24
Editor’s Choice Paper:
Experiences of patients with peritoneal carcinomatosis-related complex care needs and their caregivers
Editorial:
The importance of family-focused care in the setting of advanced gynecological cancers
Hosted by:
Sean Dowdy, MD, Associate Editor of Gynecologic...
Published 04/04/24